SCHEMBL22198146

SCHEMBL22198146

CN(C)c1ccc(/C=N/N=C/c2ccc(N3CCCC3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.59
ALDH1A1 P00352 10/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
MAPT P10636 5/20 0.49
NPC1 O15118 5/20 0.49
KDM4E B2RXH2 4/20 0.49
RAB9A P51151 4/20 0.49
GRIN2D O15399 2/20 0.49
GRIN3B O60391 2/20 0.49
GRIN1 Q05586 2/20 0.49
GRIN2A Q12879 2/20 0.49
GRIN2B Q13224 2/20 0.49
GRIN2C Q14957 2/20 0.49
GRIN3A Q8TCU5 2/20 0.49
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
FURIN P09958 1/20 0.47
TRIM24 O15164 1/20 0.47
TRIM33 Q9UPN9 1/20 0.47
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22198168 0.88 SLC2A1 (0.77) SLC2A1ALDH1A1SMN1; SMN2MAPTNPC1
SCHEMBL22198241 0.86 TRIM24 (0.61) ALDH1A1SMN1; SMN2MAPTNPC1KDM4E
SCHEMBL22198150 0.84 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MAPTNPC1KDM4E
SCHEMBL2201868 0.84 ALDH1A1 (0.51) SLC2A1ALDH1A1SMN1; SMN2MAPTNPC1
SCHEMBL27363365 0.82 ALDH1A1 (0.53) SLC2A1ALDH1A1SMN1; SMN2MAPTNPC1
Hydrochloric Acid SCHEMBL27659481 0.81 ALDH1A1 (0.55) SLC2A1ALDH1A1SMN1; SMN2MAPTNPC1
SCHEMBL30408019 0.80 ALDH1A1 (0.51) SLC2A1ALDH1A1MAPTNPC1KDM4E
SCHEMBL10909091 0.80 GRIN2D (0.68) ALDH1A1SMN1; SMN2MAPTNPC1KDM4E
SCHEMBL22198126 0.80 GRIN2D (0.68) ALDH1A1SMN1; SMN2MAPTNPC1KDM4E
SCHEMBL22198292 0.77 CA12 (0.49) ALDH1A1SMN1; SMN2MAPTNPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393810-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF HTA Co., Ltd. (CN) 2021-12-23 US disclosed
WO-2020140924-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO AΒ PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF 原子高科股份有限公司 2020-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393810-A1 DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF MAPT, APP, PSEN1 SLC2A1 2647/4885ALDH1A1 1343/4885SMN1; SMN2 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.